Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07752109.4Aexternal-prioritypatent/EP1996238B1/en
Application filed by Vaxart, Inc.filedCriticalVaxart, Inc.
Publication of CY1117623T1publicationCriticalpatent/CY1117623T1/en
Η παρούσα εφεύρεση παρέχει χιμαιρικούς αδενοϊικούς φορείς και μεθόδους χρήσης των φορέων για την πρόκληση μιας ανοσολογικής απόκρισης σε ένα αντιγόνο ενδιαφέροντος.The present invention provides chimeric adenoviral vectors and methods of using vectors to induce an immune response to an antigen of interest.
CY20161100517T2006-02-282016-06-14
CHEMICAL ADENOVES AND DsRNA AS A TOY TLR3 AGENT
CY1117623T1
(en)
anti-cd3 antibodies, isolated nucleic acid, vector, host cell, anti-cd3 antibody production method, immunoconjugate, composition, use of anti-cd3 antibody, treatment methods, methods of enhancing immune function and kit